Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × Basiliximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Hodgkin Disease 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myeloid, Acute 3 Primary Myelofibrosis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioblastoma 2 Anemia, Refractory, with Excess of Blasts 2 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Mantle-Cell 1 Hemoglobinuria, Paroxysmal 1 Gliosarcoma 1 Brain Neoplasms 1 Anemia, Aplastic 1

Interventions

Surveys and Questionnaires 95 Exercise 85 Blood Specimen Collection 79 Radiotherapy 59 Gemcitabine 51 Bevacizumab 49 Standard of Care 48 Cisplatin 48 Capecitabine 44 Dexamethasone 43 Carboplatin 43 Cyclophosphamide 42 Paclitaxel 40 Interviews as Topic 40 pembrolizumab 39 Docetaxel 38 Oxaliplatin 35 Methods 35 Irinotecan 34 Magnetic Resonance Spectroscopy 32 Fluorouracil 32 Therapeutics 27 Radiosurgery 27 Nivolumab 26 Drug Therapy 26 Educational Status 25 Leucovorin 20 Everolimus 20 Control Groups 20 Cognitive Behavioral Therapy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00903188 2009-05-18

CISTCERT

University Hospital, Antwerp

Phase 4 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡